1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
BioGaia AB (publ)

BioGaia AB (publ)

BIOGY
BioGaia AB (publ)US flagOther OTC
11.00
USD
- -
- -
1.11BMarket Cap

Total Valuation

BioGaia AB (publ) carries a market capitalization of 1.11B, placing it among publicly traded companies globally. Its enterprise value stands at 8.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.11B
Enterprise Value8.01B

Share Statistics

BioGaia AB (publ) currently has 101.16M shares outstanding.

Shares Outstanding101.16M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

BioGaia AB (publ) trades at a trailing price-to-earnings ratio of 30.12.

PE Ratio30.12
PS Ratio6.00
PB RatioN/A
P/TBV Ratio8.63
P/FCF Ratio26.79
P/OCF Ratio27.31

Enterprise Valuation

On an enterprise value basis, BioGaia AB (publ) trades at an EV/EBITDA multiple of 22.87 and an EV/FCF ratio of 23.89. The EV/Sales ratio of 5.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.87 provides insight into valuation relative to core operating earnings.

EV / Sales5.56
EV / EBITDA22.87
EV / EBIT22.87
EV / FCF23.89

Financial Position

BioGaia AB (publ) maintains a current ratio of 5.74, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.

Current Ratio5.74
Quick Ratio3.45
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage21.20

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)17.20
Return on Invested Capital (ROIC)20.22
Return on Capital Employed (ROCE)14.98M
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, BioGaia AB (publ) has paid 77.15M in income taxes, reflecting an effective tax rate of 21.21.

Income Tax77.15M
Effective Tax Rate21.21

Stock Price Statistics

BioGaia AB (publ)'s stock has gained approximately 16.03376% over the past 52 weeks. The 50-day moving average sits at 10.75, while the 200-day moving average is 10.17.

Beta (5Y)N/A
52-Week Price Change16.03376%
50-Day Moving Average10.75
200-Day Moving Average10.17
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, BioGaia AB (publ) generated 1.44B in revenue and converted that into 286.63M in net income, yielding earnings per share of 2.83. EBITDA reached 350.30M, while operating income came in at 350.30M.

Revenue1.44B
Gross Profit1.04B
Operating Income350.30M
Pretax Income363.78M
Net Income286.63M
EBITDA350.30M
EBIT350.30M
Earnings Per Share (EPS)2.83

Balance Sheet

Cash & Cash Equivalents622.34M
Total DebtN/A
Net Debt-622.34M
Equity (Book Value)N/A
Book Value Per ShareN/A
Working Capital853.70M

Cash Flow

BioGaia AB (publ) produced 316.16M in operating cash flow over the past twelve months. After subtracting -6.10M in capital expenditures, free cash flow totaled 310.06M - equivalent to 3.07 per share.

Operating Cash Flow316.16M
Capital Expenditures-6.10M
Free Cash Flow310.06M
FCF Per Share3.07

Margins

BioGaia AB (publ) operates with a gross margin of 72.45, reflecting its pricing power and cost economics. The operating margin of 24.33 and net profit margin of 19.91 provide insight into operational efficiency.

Gross Margin72.45
Operating Margin24.33
Pretax Margin25.27
Profit Margin19.91
EBITDA Margin24.33

Dividends & Yields

The company's payout ratio of 243.52 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share6.90
Dividend YieldN/A
Payout Ratio243.52
Shareholder Yield7.99
FCF Yield3.73

Stock Splits

BioGaia AB (publ)'s most recent stock split took place on May 26, 2022 with a 2:5 split ratio.

Last Split Date5/26/2022
Split Ratio2:5

Scores

BioGaia AB (publ) posts an Altman Z-Score of 21.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score21.48